Foresee Pharmaceuticals Co (ROCO:6576) Price-to-Tangible-Book : 12.52 (As of May. 06, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Foresee Pharmaceuticals Co Price-to-Tangible-Book?

As of today (2024-05-06), Foresee Pharmaceuticals Co's share price is NT$94.60. Foresee Pharmaceuticals Co's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was NT$7.56. Hence, Foresee Pharmaceuticals Co's Price to Tangible Book Ratio of today is 12.52.

The historical rank and industry rank for Foresee Pharmaceuticals Co's Price-to-Tangible-Book or its related term are showing as below:

ROCO:6576' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 6.47 Med: 10.96 Max: 15.58
Current: 11.49

During the past 10 years, Foresee Pharmaceuticals Co's highest Price to Tangible Book Ratio was 15.58. The lowest was 6.47. And the median was 10.96.

ROCO:6576's Price-to-Tangible-Book is ranked worse than
91.85% of 871 companies
in the Drug Manufacturers industry
Industry Median: 2.41 vs ROCO:6576: 11.49

A closely related ratio is called PB Ratio. As of today, Foresee Pharmaceuticals Co's share price is NT$94.60. Foresee Pharmaceuticals Co's Book Value per Sharefor the quarter that ended in Mar. 2024 was NT$8.47. Hence, Foresee Pharmaceuticals Co's P/B Ratio of today is 11.18.

Foresee Pharmaceuticals Co Price-to-Tangible-Book Historical Data

The historical data trend for Foresee Pharmaceuticals Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Foresee Pharmaceuticals Co Price-to-Tangible-Book Chart

Foresee Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

8.97

6.47

12.10

14.03

11.69

Foresee Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Tangible-Book	Get a 7-Day Free Trial															23.49	6.84	7.55	11.69	-

Competitive Comparison of Foresee Pharmaceuticals Co's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Foresee Pharmaceuticals Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Foresee Pharmaceuticals Co's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Foresee Pharmaceuticals Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Foresee Pharmaceuticals Co's Price-to-Tangible-Book falls into.

Foresee Pharmaceuticals Co Price-to-Tangible-Book Calculation

Foresee Pharmaceuticals Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2024 )
	=	94.60	/	7.557
	=	12.52

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Foresee Pharmaceuticals Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Foresee Pharmaceuticals Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Foresee Pharmaceuticals Co (ROCO:6576) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Foresee Pharmaceuticals Co Ltd (ROCO:6576) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 19-3, Sanchong Road, 9th Floor-2, Nangang District, Taipei, TWN, 115

Website

https://www.foreseepharma.com

Foresee Pharmaceuticals Co Ltd is engaged in the development and commercialization of new drugs using its proprietary drug delivery technology. Its main activity is to apply its Stabilised injectable formulation(SIF) platform technology to produce the products for anticancer and treatment of chronic disease. Its SIF product pipeline includes FP-001 for prostate cancer, FP-004 for Opioid drug addiction/Pain, FP-011 for Breast Cancer/Prostate Cancer, FP-016 for neurological diseases, and others. All of its revenue is generated from Taiwan.

Foresee Pharmaceuticals Co (ROCO:6576) Headlines

No Headlines